On Thursday, Palisade Bio’s Director, Robert Baltera Jr., purchased 30,000 shares of the company’s stock for $59,400, at a price of $1.98 per share. This investment reflects Baltera Jr.’s confidence in the company, as he is currently up approximately 9.6% based on a trading high of $2.17 today.
Palisade Bio’s stock is trading up about 4.3% on the market.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
